Good Pharma rankings for 2019 are published and Roche and Novo Nordisk, tied for the top ranking in overall transparency; each with scores of 100%. The complete list is available here.
The Good Pharma Scorecard ranks companies and new medicines on their clinical trial transparency and data-sharing performance, taking into account ethics and legal standards. The measures included in overall company transparency were as follows:
| Category | Measures |
| Data sharing applicable trials | Registration by deadline |
| Policy provides access to analysis ready dataset and clinical study report | |
| Policy explains how data might be requested | |
| Company reports number and outcome of data requests | |
| Policy specifies data will be shared by deadline | |
| Trials in patients | Registration of trial and results publicly available by 6 months after primary completion date (reported or published) |
| Food and Drug Administration Amendments Act trials | Registration by 21 days of trial start date and results reported by 30 days after approval by FDA of indication studied |
The detailed scorecard methodology is available here. For a PDF version, click here.